VRTX
VRTX
NASDAQ · Biotechnology

Vertex Pharmaceuticals Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$446.54
+3.38 (+0.76%)
As of Mar 31, 9:31 PM ET ·
Analyst Consensus
Strong Buy
39
Analysts
Very High
Coverage
Buy 31 79%
Hold 7 18%
Sell 1 3%
Price Target
Analyst Price Target -1.8% upside
Low Target $313.95
Average Target $438.34
High Target $454.41
Current Price $446.54
Current
$446.54
Target
$438.34
$313.95 $438.34 avg $454.41
Scenario Analysis
Bear Case
$313.95
-29.7%
Low target
Base Case
$438.34
-1.8%
Avg target
Bull Case
$454.41
+1.8%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$510.77
-12.6% from high
52-Week Low
$362.50
+23.2% from low
50-Day SMA
$461.14
-3.2% vs SMA
200-Day SMA
$435.10
+2.6% vs SMA
RSI (14)
47.3
Neutral
Target vs 52W High
$438.34
-14.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
 Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -28.5%